These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 8041306

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Protective effect of Bacteroides fragilis LPS on Escherichia coli LPS-induced inflammatory changes in human monocytic cells and in a rheumatoid arthritis mouse model.
    Kitamura K, Sasaki M, Matsumoto M, Shionoya H, Iida K.
    Immunol Lett; 2021 May; 233():48-56. PubMed ID: 33741378
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The spectrum of Escherichia coli--Bacteroides fragilis pathogenic synergy in an intraabdominal infection model.
    Rotstein OD, Kao J.
    Can J Microbiol; 1988 Mar; 34(3):352-7. PubMed ID: 3046726
    [Abstract] [Full Text] [Related]

  • 7. Synergy of Bacteroides fragilis and Escherichia coli in the induction of KC gene expression in mouse peritoneal tissues.
    Kim JM, Kim YJ, Cho YJ.
    Scand J Infect Dis; 2000 Mar; 32(6):643-9. PubMed ID: 11200375
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
    Stearne LE, Gyssens IC, Goessens WH, Mouton JW, Oyen WJ, van der Meer JW, Verbrugh HA.
    Antimicrob Agents Chemother; 2001 May; 45(5):1394-401. PubMed ID: 11302801
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4.
    Mancuso G, Midiri A, Biondo C, Beninati C, Gambuzza M, Macrì D, Bellantoni A, Weintraub A, Espevik T, Teti G.
    Infect Immun; 2005 Sep; 73(9):5620-7. PubMed ID: 16113279
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Experimental intraabdominal abscess formation by Escherichia coli and bacteroides fragilis.
    Hagen JC, Wood WS, Hashimoto T.
    Eur J Clin Microbiol; 1983 Feb; 2(1):43-9. PubMed ID: 6341050
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis.
    Shapiro ME, Kasper DL, Zaleznik DF, Spriggs S, Onderdonk AB, Finberg RW.
    J Immunol; 1986 Jul 01; 137(1):341-6. PubMed ID: 3486915
    [Abstract] [Full Text] [Related]

  • 19. Susceptibility of the liver and biliary tract to anaerobic infection in extrahepatic biliary tract obstruction. III. Possible synergistic effect between anaerobic and aerobic bacteria. An experimental study in rabbits.
    Lykkegaard Nielsen M, Asnaes S, Justesen T.
    Scand J Gastroenterol; 1976 Jul 01; 11(3):263-72. PubMed ID: 775613
    [Abstract] [Full Text] [Related]

  • 20. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
    Lindberg AA, Weintraub A.
    Scand J Infect Dis Suppl; 1985 Jul 01; 46():27-32. PubMed ID: 3865350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.